SCHEMBL7929013

SCHEMBL7929013

CC(=O)CCC(C(=O)O)C(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.52
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.45
NPC1 O15118 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
PGR P06401 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
HTR2A P28223 1/20 0.43
HRH1 P35367 1/20 0.43
KCNH2 Q12809 1/20 0.43
CTNNB1 P35222 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP3A4 P08684 1/20 0.42
CES2 O00748 3/20 0.41
CES1 P23141 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7940474 0.86 KMT2A (0.44) ALDH1A1MAPTNPC1RAB9AADRA2B
SCHEMBL13998335 0.84 TDP1 (0.49) MDM2ALDH1A1MAPTNPC1HTT
SCHEMBL11017982 0.81 MDM2 (0.52) MDM2ALDH1A1MAPTNPC1MAPK1
SCHEMBL517168 0.81 MDM2 (0.55) MDM2MAPTNPC1MAPK1HTT
SCHEMBL29029678 0.80 MDM2 (0.50) MDM2ALDH1A1MAPTNPC1MAPK1
SCHEMBL9049808 0.79 MDM2 (0.53) MDM2MAPTNPC1MAPK1HTT
SCHEMBL27846721 0.79 MDM2 (0.57) MDM2ALDH1A1MAPTNPC1MAPK1
SCHEMBL29029682 0.79 MDM2 (0.57) MDM2ALDH1A1MAPTNPC1MAPK1
SCHEMBL9356287 0.78 MDM2 (0.52) MDM2ALDH1A1MAPTNPC1MAPK1
SCHEMBL14011220 0.77 ALDH1A1 (0.42) MDM2ALDH1A1MAPTNPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010020112-A1 Process for preparing (hetero) aromatic substituted benzene derivatives TOYA TETSUYA (JP) 2001-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020112-A1 Process for preparing (hetero) aromatic substituted benzene derivatives AHR, CYP3A4, CYP4B1 MDM2 509/4885ALDH1A1 1596/4885MAPT 4234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.